CCL Industries, Inc.

CCL Industries Inc., often referred to as CCL, is a Canadian-American specialty packaging company headquartered in Toronto, Canada, and Framingham, Massachusetts. Founded in 1951 as Connecticut Chemicals (Canada) Limited, the company rebranded to CCL Industries in 1979. It is a publicly traded company on the Toronto Stock Exchange under the ticker symbol CCL.B, and is an S&P/TSX 60 Component. As of early 2026, CCL Industries employs approximately 26,000 people across 214 production facilities in 42 countries. The company reported annual revenues of CDN$7.2 billion for 2024 and a trailing 12-month revenue of $5.51 billion USD for 2025, with a market capitalization of $10.6 billion as of May 11, 2026.

CCL describes itself as the world's largest label maker, providing a wide array of products and services through its five divisions: CCL Label, CCL Container, Avery, Checkpoint, and Innovia. CCL Label produces pressure-sensitive and specialty extruded film materials for decorative, instructional, functional, and security applications across consumer packaging, healthcare, chemicals, electronics, and automotive markets. Avery is a major supplier of labels, specialty converted media, and software for digital printing. Checkpoint Systems develops RF and RFID-based technology for loss prevention and inventory management in retail, while Innovia specializes in high-performance, multi-layer films for labels, packaging, and security. CCL Container produces plastic tubes, aluminum aerosols, and specialty bottles.

In terms of patent litigation, CCL Industries Inc. appears to be an active two-way litigant. The company is involved in two tracked cases, having appeared once as a plaintiff and once as a defendant. Both cases, initiated in late 2024 and early 2025, involve Brook & Whittle Ltd. CCL Industries Inc. is defending a suit brought by Brook & Whittle Ltd. in the Delaware District Court, while simultaneously pursuing a plaintiff case against Brook & Whittle Ltd. at the Patent Trial and Appeal Board (PTAB). This suggests a direct patent dispute between two operating companies, likely involving assertions of infringement and challenges to patent validity.